Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test
Share this article Share this article - SARS-CoV-2 IgG II Quant antibody test measures levels of IgG antibodies to help measure and understand a person's immune response - The test specifically identifies levels of IgG antibodies that attach to the virus' spike protein which can be helpful to evaluate a person's immune response to vaccines - CE Mark test will be available for use on Abbott's ARCHITECT® and Alinity i™ platforms - Abbott plans to submit its test for U.S. Food and Drug Administration (FDA) emergency use authorization soon ABBOTT PARK, Illinois, Dec. 15, 2020 /PRNewswire/ -- ...
Source: prnewswire.co.uk